ANTIFUNGAL LIQUID SPRAY

N/A

Manufactured by ARMY & AIR FORCE EXCHANGE SERVICE

575 FDA adverse event reports analyzed

Last updated: 2026-04-15

About ANTIFUNGAL LIQUID SPRAY

ANTIFUNGAL LIQUID SPRAY is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ARMY & AIR FORCE EXCHANGE SERVICE. The most commonly reported adverse reactions for ANTIFUNGAL LIQUID SPRAY include ARTHRALGIA, DIARRHOEA, HEADACHE, RASH ERYTHEMATOUS, BLOOD POTASSIUM INCREASED. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for ANTIFUNGAL LIQUID SPRAY.

Top Adverse Reactions

ARTHRALGIA17 reports
DIARRHOEA16 reports
HEADACHE13 reports
RASH ERYTHEMATOUS13 reports
BLOOD POTASSIUM INCREASED12 reports
BRONCHOPULMONARY ASPERGILLOSIS11 reports
DYSPNOEA11 reports
MUCORMYCOSIS11 reports
OFF LABEL USE11 reports
RENAL IMPAIRMENT11 reports
SKIN LESION11 reports
BACK PAIN10 reports
FATIGUE10 reports
GASTROINTESTINAL DISORDER10 reports
PNEUMONIA10 reports
TOOTH DISORDER10 reports
VOMITING10 reports
ACUTE KIDNEY INJURY9 reports
BONE PAIN8 reports
DEPRESSION8 reports
DRUG INEFFECTIVE8 reports
ENAMEL ANOMALY8 reports
NAUSEA8 reports
PRURITUS8 reports
TOOTH HYPOPLASIA8 reports
WOUND8 reports
ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE7 reports
ACUTE GRAFT VERSUS HOST DISEASE IN SKIN7 reports
C REACTIVE PROTEIN INCREASED7 reports
CANCER PAIN7 reports
CHRONIC GRAFT VERSUS HOST DISEASE7 reports
DISEASE PROGRESSION7 reports
MUCOSAL INFLAMMATION7 reports
OEDEMA PERIPHERAL7 reports
RASH7 reports
DIZZINESS6 reports
DRUG INTERACTION6 reports
ERYTHEMA6 reports
PAIN6 reports
PAIN IN EXTREMITY6 reports
URTICARIA6 reports
CHRONIC KIDNEY DISEASE5 reports
FALL5 reports
PRODUCT USE IN UNAPPROVED INDICATION5 reports
ABDOMINAL PAIN4 reports
ALANINE AMINOTRANSFERASE INCREASED4 reports
ANXIETY4 reports
ASTHENIA4 reports
BLOOD ALKALINE PHOSPHATASE INCREASED4 reports
BLOOD UREA INCREASED4 reports
CARPAL TUNNEL SYNDROME4 reports
CATARACT4 reports
CONDITION AGGRAVATED4 reports
CONSTIPATION4 reports
DIABETES MELLITUS4 reports
HYPERSENSITIVITY4 reports
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION4 reports
INSOMNIA4 reports
INTERVERTEBRAL DISC PROTRUSION4 reports
MALAISE4 reports
MUSCULOSKELETAL STIFFNESS4 reports
MYALGIA4 reports
OEDEMA4 reports
PERIPHERAL SWELLING4 reports
POLLAKIURIA4 reports
PRODUCT DOSE OMISSION ISSUE4 reports
PYREXIA4 reports
RENAL FAILURE4 reports
SINUSITIS4 reports
WHITE BLOOD CELL COUNT INCREASED4 reports
ABDOMINAL PAIN UPPER3 reports
AMNESIA3 reports
ARTHRITIS3 reports
BALANCE DISORDER3 reports
BLOOD CREATININE DECREASED3 reports
BURNING SENSATION3 reports
CARBON DIOXIDE INCREASED3 reports
CHEST DISCOMFORT3 reports
COGNITIVE DISORDER3 reports
DEATH3 reports
DEHYDRATION3 reports
DRUG LEVEL INCREASED3 reports
DYSSTASIA3 reports
ERECTILE DYSFUNCTION3 reports
GAIT DISTURBANCE3 reports
GRAFT VERSUS HOST DISEASE3 reports
HAEMOPTYSIS3 reports
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS3 reports
JOINT SWELLING3 reports
NECK PAIN3 reports
NEUROPATHY PERIPHERAL3 reports
PRODUCTIVE COUGH3 reports
RASH PRURITIC3 reports
RED BLOOD CELL COUNT INCREASED3 reports
SWELLING3 reports
TREMOR3 reports
VISUAL IMPAIRMENT3 reports
ABDOMINAL DISCOMFORT2 reports
ABSCESS LIMB2 reports
ANGIOEDEMA2 reports

Report Outcomes

Out of 181 classified reports for ANTIFUNGAL LIQUID SPRAY:

Serious 77.9%Non-Serious 22.1%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male84 (50.0%)
Female84 (50.0%)

Reports by Age

Age 629 reports
Age 97 reports
Age 637 reports
Age 515 reports
Age 605 reports
Age 725 reports
Age 755 reports
Age 614 reports
Age 183 reports
Age 413 reports
Age 573 reports
Age 673 reports
Age 683 reports
Age 703 reports
Age 713 reports
Age 733 reports
Age 763 reports
Age 843 reports
Age 212 reports
Age 272 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with ANTIFUNGAL LIQUID SPRAY?

This profile reflects 575 FDA FAERS reports that mention ANTIFUNGAL LIQUID SPRAY. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for ANTIFUNGAL LIQUID SPRAY?

Frequently reported terms in FAERS include ARTHRALGIA, DIARRHOEA, HEADACHE, RASH ERYTHEMATOUS, BLOOD POTASSIUM INCREASED, BRONCHOPULMONARY ASPERGILLOSIS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures ANTIFUNGAL LIQUID SPRAY?

Labeling and FAERS entries often list ARMY & AIR FORCE EXCHANGE SERVICE in connection with ANTIFUNGAL LIQUID SPRAY. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.